Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 797 results for "Shionogi"

Removing Early Barriers To Drugs For Neglected Diseases
Asian Scientist

DNDi and 4 cos team up to accelerate drug discovery for world'...

Drugs for Neglected Diseases initiative (DNDi) and four pharmaceutical firms, Eisai Co Ltd, Shionogi & Co Ltd, Takeda Pharmaceutical Ltd, and AstraZeneca plc have announced the start of a ground-breaking initiative to accelerate and cut the cost of ... PharmaBiz, 1 month ago

4 images for Shionogi

IChainnel, 2 days ago
Asian Scientist, 2 weeks ago
ClinicSpace, 3 months ago
PR Newswire, 3 months ago

GSK reins in drug sell off

GLAXOSMITHKLINE has dropped plans to float its HIV drug business. ViiV, its joint venture with Pfizer and Japan's Shionogi, could have been valued at about £15billion but Glaxo said its decision to retain the business reflects its strong positive ...
 Scottish Daily Express1 month ago GSK Cuts Return to Holders From Novartis Asset Swap  Morningstar.com1 month ago GSK shelves ViiV IPO and rules out mega-merger  Pharma Field1 month ago
[x]  

SHIONOGI ANNOUNCES THAT NALDEMEDINE MET THE PRIMARY ENDPOINT IN ITS FIRST JAPANESE PHASE 3 STUDY FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION IN CANCER PATIENTS

 Noodls1 week ago Naldemedine shows promise in treating OIC in patients with chronic non-cancer pain.  News-Medical.Net1 month ago Phase IIb Data Show Once-Daily Naldemedine Provides Significant Improvement For Patients With Opioid-Induced Constipation  PR Newswire1 month ago Shionogi, Inc. Release: Phase IIb Data Show Once-Daily Naldemedine Provides Significant Improvement For Patients With Opioid-Induced Constipation 5/19/2015  ClinicSpace1 month ago
[x]  
Malay Mail

Nikkei edges up but investors still bewitched by Greece Reuters

* Market wants to wait until Greece's referendum - traders * China market moves focused - traders * Shionogi soars after Credit Suisse's rating hike By Ayai Tomisawa TOKYO, June 30 (Reuters) - Japan's Nikkei share average ...
 Yahoo! Finance4 days ago Nikkei rebounds on buybacks  Japan Times4 days ago Nikkei edges up but Greece uncertainty still looms  Hindu Business Line4 days ago Japan shares fluctuate as investors assess possible Greek fallout  Malay Mail4 days ago
[x]  
IChainnel

GSK's ViiV turns to Chinese company for cheap supply of Tivicay API

The HIV-oriented joint venture of Pfizer ($PFE), GlaxoSmithKline ($GSK) and Japan's Shionogi is turning to a Chinese manufacturer for a cheap supply of dolutegravir, the active ingredient in its Tivicay. The deal is seen as a way to cut the cost in ...
 IChainnel2 days ago

Investigation Report on China Rosuvastatin Market, 2010-2019

First developed by Shionogi Inc. under the code name of S-4522 at the end of 1980s, rosuvastatin (rosuvastatin calcium) along with its development, marketing and sales rights, was transferred to AstraZeneca in Jun. 1998 under the code name of ...
 MarketResearch.com1 week ago

Shionogi to Issue of Stock Options as Compensation (Stock Acquisition Rights) to Members of Board of Directors

 Noodls1 week ago

Shionogi : Researchers at Shionogi & Co. Ltd. Release New Data on Nerve Tissue Proteins [Development of an Optimized Synthetic and Purification Process of...

Researchers at Shionogi & Co. Ltd. Release New Data on Nerve Tissue Proteins [Development of an Optimized Synthetic and Purification Process of S-2367 (Velneperit), a Novel Neuropeptide Y (NPY) Y5 Receptor Antagonist] By a News Reporter-Staff ...
 4 Traders1 month ago

ViiV Healthcare inks agreement with Desano for manufacture of dolutegravir API in China

ViiV Healthcare, a global specialist HIV company, and Desano Pharmaceuticals (Desano), a leading vertically integrated pharmaceuticals company, announced a strategic manufacturing agreement to enable production of dolutegravir in China. The ...
 PharmaBiz12 hours ago China's Desano Pharma to Make API for New HIV Drug for ViiV  Financial Content1 day ago ViiV Healthcare And Manufacturing Agreement Will Allow Competitive Supply Of Dolutegravir In China And Several Developing Countries  BioSpace2 days ago GSK share price: HIV unit inks deal with China's Desano Pharmaceuticals  Invezz2 days ago
[x]  
This is Money

Relations between GlaxoSmithKline and China thawing as drug maker announces deal to make HIV medicine with Shanghai firm Desano

By Published: View comments Relations between GlaxoSmithKline and China appear to be thawing as Britain's biggest drug maker announced a deal to make HIV medicine with Shanghai firm Desano Pharmaceuticals. GSK's ViiV Healthcare unit will supply the ...
 This is Money1 day ago GlaxoSmithKline's ViiV Healthcare, Desano to offer China "competitive supply" of HIV drug Tivicay  FirstWord Pharma2 days ago ViiV Healthcare, Desano to offer China "competitive supply" of GlaxoSmithKline's HIV drug Tivicay  FirstWord Pharma14 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less